RESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: The parts of the Genipa americana (Rubiaceae) tree, also known as "jenipapo" or "jenipapeiro", has been used in traditional Medicine in parasitic and bacterial infections. Thus, the experimental evolution of the antiparasitic activity of polysaccharide extracts from Genipa americana leaves, and correlation with antiparasitic and popular use is important. AIM OF THE STUDY: To evaluate the effect of polysaccharide extract obtained from Genipa americana leaves on all Trypanosoma cruzi (Y strain: benznidazole-resistant) developmental forms, a protozoan that causes Chagas' disease. MATERIALS AND METHODS: An extract rich in polysaccharides was obtained from the leaves of Genipa americana (GaEPL) by associating depigmentation in methanol followed by extraction of polysaccharides in NaOH and precipitation with ethanol. Cytotoxicity to mammalian cells (LLC-MK2) was determined using an MTT assay. Antiparasitic activity was evaluated against epimastigote, trypomastigote and amastigote forms of T. cruzi. Cell-death mechanism was determined in epimastigote forms by flow cytometry analysis after FITC-annexin V (Ax), 7-AAD, and H2DCFDA staining. Striking morphological changes were observed by scanning electron microscope. RESULTS: GaEPL (6.5% yield; 54.6% total carbohydrate; 21.1% uronic acid and 12% protein), inhibited all T. cruzi developmental forms, epimastigotes after periods of 24h (IC50 = 740 ± 0.075µg/mL), 48h (IC50 = 710 ± 0.053µg/mL) and 72h (IC50 = 870 ± 0.052µg/mL) of incubation; trypomastigotes (IC50 = 470 ± 0.082µg/mL) after periods of 24h and intracellular amastigotes (IC50/2 = 235 or IC50 = 470µg/mL) after periods of 24 and 48h of incubation, with no toxicity on LLC-MK2 cells at the used concentrations. Analysis of the possible action mechanism in the parasites suggested cell death by necrosis with the involvement of reactive oxygen species (ROS). The scanning electron microscopy (SEM) confirmed T. cruzi death by necrosis. CONCLUSIONS: GaEPL showed significant activity against the epimastigote, trypomastigote and amastigote forms of T. cruzi, strain Y, suggesting cell death by necrosis with involvement of reactive oxygen species.
Asunto(s)
Extractos Vegetales/farmacología , Rubiaceae/química , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Muerte Celular/efectos de los fármacos , Línea Celular , Citometría de Flujo , Concentración 50 Inhibidora , Macaca mulatta , Microscopía Electrónica de Rastreo , Extractos Vegetales/administración & dosificación , Hojas de la Planta , Polisacáridos/administración & dosificación , Polisacáridos/aislamiento & purificación , Polisacáridos/farmacología , Especies Reactivas de Oxígeno/metabolismo , Factores de Tiempo , Tripanocidas/administración & dosificación , Tripanocidas/aislamiento & purificaciónRESUMEN
Chagas' disease is a neglected disease caused by the protozoan parasite Trypanosoma cruzi and constitutes a serious health problem worldwide. The treatment is limited, with variable efficacy of benznidazole and nifurtimox. Betulinic Acid (BA), a triterpene, can be found in medicinal herbs and has a wide variety of biological and pharmacological activities. The objective was to evaluate betulinic acid effects on the cell death mechanism in Trypanosoma cruzi strain Y. BA inhibited the growth of epimastigotes in periods of 24h (IC50=73.43µM), 48h (IC50=119.8µM) and 72h (IC50=212.2µM) of incubation; of trypomastigotes (IC50=51.88µM) in periods of 24h and intracellular amastigotes (IC50=25.94µM) in periods of 24 and 48h of incubation, no toxicity on LLC-MK2 cells at the concentrations used. Analysis of the possible mechanism of parasite cell death showed alterations in mitochondrial membrane potential, alterations in cell membrane integrity, an increase in the formation of reactive oxygen species and increase swelling of the reservosomes. In conclusion, betulinic acid was be able to inhibition all developmental forms of Trypanosoma cruzi Y strain with necrotic mechanism and involvement of mitochondrial membrane potential alteration and increase in reactive oxygen species.
Asunto(s)
Muerte Celular/efectos de los fármacos , Enfermedad de Chagas/tratamiento farmacológico , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Triterpenos/farmacología , Triterpenos/uso terapéutico , Tripanocidas/uso terapéutico , Trypanosoma cruzi/efectos de los fármacos , Animales , Humanos , Necrosis , Triterpenos Pentacíclicos , Tripanocidas/farmacología , Ácido BetulínicoRESUMEN
Neglected tropical diseases (NTD) are treated with toxic therapy of limited efficacy. Previously, we studied the antimicrobial effect of Dinoponera quadriceps venom (DqV) against bacteria. To continue the study, we report in this short communication the antimicrobial effect of DqV against Leishmania amazonensis and Trypanosoma cruzi. DqV inhibits the promastigote forms of L. amazonensis and all T. cruzi developmental forms, with low toxicity in host cells. DqV causes cell death in T. cruzi through necrotic and apoptotic mechanisms observed by staining the cells with annexin V-FITC (AX) and propidium iodide (PI), loss of mitochondrial membrane potential by flow cytometry analyses and confocal microscopy and morphological alterations, such as loss of membrane integrity and cell shrinkage by scanning electron microscopy (SEM). In conclusion, we suggest there is an antimicrobial effect also on parasites.
Asunto(s)
Venenos de Hormiga/uso terapéutico , Hormigas , Leishmania/efectos de los fármacos , Trypanosoma/efectos de los fármacos , Animales , Venenos de Hormiga/administración & dosificación , Línea Celular , Relación Dosis-Respuesta a Droga , Leishmania/crecimiento & desarrollo , Leishmania/ultraestructura , Macaca mulatta , Microscopía Electrónica de Rastreo , Trypanosoma/crecimiento & desarrollo , Trypanosoma/ultraestructuraRESUMEN
The South American giant ant, Dinoponera quadriceps (Hymenoptera, Formicidae, Ponerinae), produces proteinaceous venom that has antinociceptive, neuroprotective and antimicrobial effects, thereby supporting the popular use of these ants to treat asthma, rheumatism, earache and back pain. Anticoagulant activity is another biological property that has been shown for the venom of other hymenopteran species, like wasps. The aim of this study was to assess the anti-inflammatory, anticoagulant and antiplatelet properties of D. quadriceps venom (DqV). DqV anti-inflammatory activity was assessed by intravenous administration in Swiss mice in the models of paw edema and peritonitis. In vitro, DqV was assessed in coagulation (activated partial thromboplastin time) and platelet aggregation tests. DqV inhibited (27-33%) the edema elicited by carrageenan and the leucocyte migration (43%) elicited by zymosan. DqV decreased by 57% and 42%, respectively, the content of malondialdehyde and nitrite in the peritoneal fluid. DqV prolonged (1.8x) the clotting time and decreased (27%) the platelet aggregation induced by adenosine diphosphate. The crude venom of D. quadriceps presents an anti-inflammatory effect in mice and in vitro anticoagulant and antiplatelet effects.
Asunto(s)
Venenos de Hormiga/farmacología , Antiinflamatorios/farmacología , Hormigas/fisiología , Animales , Venenos de Hormiga/química , Antiinflamatorios/química , Carragenina/toxicidad , Edema/inducido químicamente , Edema/tratamiento farmacológico , Femenino , Ratones , Peritonitis/inducido químicamente , Peritonitis/tratamiento farmacológico , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria , Zimosan/toxicidadRESUMEN
The objective of this study was to evaluate the antinociceptive effects of a lectin from Canavalia brasiliensis (ConBr) when administered orally to murine models of chemical and thermal nociception. ConBr up to 100 mg/kg produced significant and dose-dependent antinociceptive effects: 81% reduction in abdominal writhing induced by 0.6% acetic acid; 26 and 52% reduction in early- and late-stage paw licking, respectively, induced by 2.5% formalin; and 155% increase in reaction latency (heightened thermal pain threshold). In all models, the antinociceptive effect was reversed by the lectin-binding carbohydrate α-d-methyl-mannoside and by the nonselective opioid antagonist naloxone. The antinociceptive effect observed in the formalin test was inhibited by the δ-selective antagonist naltrindole and the κ-selective antagonist nor-binaltorphimine but not by the µ-selective antagonist cyprodime. In conclusion, when administered orally to Swiss mice, the ConBr lectin displayed antinociceptive activity, both peripheral and central, mediated by the opioid system and involving δ-and κ-receptors and the lectin domain.